K. Urabe et al., ROLE OF ENDOGENOUS ANGIOTENSIN-II IN RENAL HEMODYNAMIC AND EXCRETORY RESPONSES TO L-ARGININE INFUSION, Biological & pharmaceutical bulletin, 19(9), 1996, pp. 1149-1153
The purpose of this study was to investigate whether endogenous angiot
ensin II has a functional role in renal hemodynamic and excretory chan
ges induced by L-arginine, a substrate for nitric oxide (NO), in anest
hetized rats. During the intravenous infusion of L-arginine (50, 100,
200 pmol/kg . min), there was no significant change in systemic or ren
al hemodynamics, but urine how and urinary sodium excretion markedly i
ncreased in a dose-dependent manner. Simultaneously, L-arginine infusi
on produced an increase in urinary excretion of NO metabolites, NO2- a
nd NO3-. Treatment with L-158809 biphenyl-4-yl]methyl]-H-3-imidazo-[4,
5-b]pyridine} (0.3 mg/kg), a selective angiotensin II type I receptor
antagonist, caused a reduction in mean arterial pressure, and a rise i
n renal blood flow and glomerular filtration rate, with no changes in
excretory responses. In the presence of L-158809, L-arginine-induced d
iuretic and natriuretic actions were observed to the same extent as se
en in the absence of L-158809. These data suggest that the infusion of
L-arginine causes diuresis and natriuresis, possibly via the formatio
n of nitric oxide in the kidney, and that endogenous angiotensin II is
not involved in the L-arginine-induced renal actions.